Melanotan 2

• API
• Melanotan
• Dosage10 mg
• Packing3 ml vial

Melanotan 2 was initially developed as a potential preventive treatment for certain types of skin cancer. Researchers proposed that artificially stimulating the body’s natural tanning response in individuals with high sun exposure risk could help reduce their likelihood of developing skin cancer later in life. In addition to promoting skin pigmentation without significant sun exposure, Melanotan 2 has been associated with enhanced sexual desire and performance. It may also exert a mild appetite-suppressing effect by acting on specific receptors in the brain. Although this effect is modest, many users find it noticeable and beneficial. After discontinuing use, the resulting tan typically fades within four to eight weeks, depending on individual factors.